| scholarly article | Q13442814 |
| P2093 | author name string | Donna Freeman | |
| Jonathan C Stephens | |||
| Arthur K Turner | |||
| Roger Randall | |||
| Juliet C Beavis | |||
| Michael J Darsley | |||
| Cornelia Gewert | |||
| Judith Greenwood | |||
| P2860 | cites work | Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention | Q24530558 |
| Diarrheagenic Escherichia coli | Q24533466 | ||
| High efficiency transformation of E. coli by high voltage electroporation | Q29615278 | ||
| Toxins and colonization factor antigens of enterotoxigenic Escherichia coli among residents of Jakarta, Indonesia | Q31003367 | ||
| IS1414, an Escherichia coli insertion sequence with a heat-stable enterotoxin gene embedded in a transposase-like gene | Q33591956 | ||
| Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins | Q33755999 | ||
| Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt | Q33962543 | ||
| Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans | Q34008614 | ||
| Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli | Q34090631 | ||
| Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults | Q34334202 | ||
| Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I | Q34334284 | ||
| Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. | Q34786549 | ||
| Rectification of two Escherichia coli heat-stable enterotoxin allele sequences and lack of biological effect of changing the carboxy-terminal tyrosine to histidine | Q35091444 | ||
| Gene encoding the major subunit of CS1 pili of human enterotoxigenic Escherichia coli. | Q35107337 | ||
| MudSacI, a transposon with strong selectable and counterselectable markers: use for rapid mapping of chromosomal mutations in Salmonella typhimurium | Q35580672 | ||
| A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phas | Q35598235 | ||
| Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation. | Q36172686 | ||
| Isolation and nucleotide sequence determination of a gene encoding a heat-stable enterotoxin of Escherichia coli | Q36346098 | ||
| Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease | Q36708480 | ||
| Phenotypic profiles of enterotoxigenic Escherichia coli associated with early childhood diarrhea in rural Egypt | Q37702938 | ||
| Detection of Heat-Labile Escherichia coli Enterotoxin with the Use of Adrenal Cells in Tissue Culture | Q38538612 | ||
| Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh | Q39454591 | ||
| Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report). | Q39591612 | ||
| Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli | Q39820829 | ||
| Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli | Q41491528 | ||
| Cloning, sequencing, and expression in Ficoll-generated minicells of an Escherichia coli heat-stable enterotoxin gene | Q42653355 | ||
| CooC and CooD are required for assembly of CS1 pili | Q42692940 | ||
| Phenotypic diversity of enterotoxigenic Escherichia coli (ETEC) isolated from cases of travelers' diarrhea in Kenya | Q44420115 | ||
| Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine | Q50174904 | ||
| Purification of the B-subunit oligomer of Escherichia coli heat-labile enterotoxin by heterologous expression and secretion in a marine vibrio. | Q54636618 | ||
| CooB is required for assembly but not transport of CS1 pilin | Q54684188 | ||
| Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries | Q57937554 | ||
| P433 | issue | 12 | |
| P921 | main subject | Escherichia coli | Q25419 |
| enterotoxigenic Escherichia coli | Q265214 | ||
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | 2128-2135 | |
| P577 | publication date | 2011-10-12 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B. | |
| P478 | volume | 18 |
| Q35598235 | A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phas |
| Q35935738 | A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles |
| Q26859729 | Acute diarrheal disease caused by enteropathogenic Escherichia coli in Colombia |
| Q30409778 | Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing Anti-STa antibodies |
| Q61806436 | Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS) |
| Q35023488 | Conservation and immunogenicity of novel antigens in diverse isolates of enterotoxigenic Escherichia coli. |
| Q42250403 | Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate |
| Q37341318 | Enterotoxigenic Escherichia coli: Orchestrated host engagement. |
| Q88814105 | Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development |
| Q93088615 | Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection |
| Q53696162 | Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development. |
| Q64109788 | Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge |
| Q37545078 | Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IV. |
| Q34349166 | Novel antigens for enterotoxigenic Escherichia coli vaccines |
| Q38032878 | Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans |
| Q35920317 | Protective Enterotoxigenic Escherichia coli Antigens in a Murine Intranasal Challenge Model |
| Q34375210 | Recent advances in understanding enteric pathogenic Escherichia coli. |
| Q38006998 | Recent progress toward an enterotoxigenic Escherichia coli vaccine |
| Q33578045 | Vaccines against human diarrheal pathogens: current status and perspectives |
Search more.